Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets.
What Jagsonpal files
- Others57
- Important36
- Investor Meet36
- Updates18
- Dividend/Bonus9
- Board Meeting7
Jagsonpal Pharma is ensuring shareholder access to the 2025-26 Annual Report and 47th AGM notice. Shareholders without registered emails received web-links for these documents. The AGM will be held virtually.
Jagsonpal Pharma allotted 27,950 equity shares to employees via its ESOP 2022. This issuance raised approximately Rs. 0.31 Cr from option exercises, expanding the company's total shares outstanding and enhancing employee participation.
Jagsonpal Pharma has completed the acquisition of an 85% equity stake in Aequitas Healthcare. This finalizes a significant business expansion, bolstering the company's operational presence.
Jagsonpal Pharma allotted 94,000 equity shares through its ESOP to employees, increasing paid-up capital from Rs. 13.17 Cr to Rs. 13.19 Cr. This expands the equity base and rewards employees.
Jagsonpal Pharma completed the acquisition of 77.21% equity stake in Aequitas Healthcare Private Limited. This advances its previously announced target to acquire 85% ownership.